Difference between rs and cvs causes if breathlessness
Reading File
Finding Sources
Searching PubMed
"dyspnea" AND "differential diagnosis"
Searching the Web
difference between respiratory and cardiac causes of breathlessness
Reading File
Reading File
I have enough authoritative content now to give a complete answer combining the textbook (Goldman-Cecil Medicine) material with clinical differentiators.
Breathlessness (Dyspnea): Respiratory (RS) vs Cardiovascular (CVS) Causes
Both systems commonly cause dyspnea, and the two often overlap (heart failure causes pulmonary congestion, for example), but there are useful distinguishing features.
1. Mechanism
- CVS causes: Dyspnea mainly results from a rise in pulmonary venous/capillary pressure due to left ventricular failure or valvular disease, causing pulmonary congestion, or from reduced cardiac output/myocardial ischemia (Goldman-Cecil Medicine, p. 2514-2520).
- RS causes: Dyspnea results from airway obstruction, loss of lung compliance, impaired gas exchange (V/Q mismatch), or increased work of breathing due to parenchymal, airway, or pleural disease.
2. Common causes
Cardiovascular (CVS):
- Left ventricular/congestive heart failure
- Myocardial ischemia/infarction
- Valvular heart disease (mitral stenosis, aortic stenosis)
- Arrhythmias (atrial fibrillation, SVT)
- Pericardial tamponade
- Severe hypertension
- Pulmonary embolism (vascular, sits between both systems)
Respiratory (RS):
- Asthma / COPD (bronchoconstriction, airway obstruction)
- Pneumonia, bronchitis
- Pneumothorax
- Pleural effusion
- Interstitial lung disease / pulmonary fibrosis
- Upper airway obstruction
3. Character of the breathlessness (key clinical clue)
Per Goldman-Cecil Medicine (p. 2518):
- Heart failure: described as "air hunger" - an urge or need to breathe.
- Airway obstruction or neuromuscular disease: feels like breathing requires increased work or effort.
- Bronchoconstriction (asthma/COPD, but also pulmonary edema): a feeling of chest tightness or constriction.
- Deconditioning: feeling of heavy or rapid breathing, or a need to "breathe more."
4. Positional and temporal patterns
- Orthopnea (worse lying flat, relieved sitting up) and paroxysmal nocturnal dyspnea (waking at night gasping for air, needing to sit/stand) are classic for heart failure - caused by increased venous return to the pulmonary circulation and loss of gravitational assistance to diaphragmatic effort (Goldman-Cecil Medicine, p. 2520).
- Respiratory causes (e.g., COPD, asthma) tend to be more persistent, exertional, and less dramatically positional, though severe COPD can also worsen supine.
- Diuresis characteristically relieves cardiac dyspnea, though not always in proportion to fluid lost.
5. Associated signs/symptoms
| Feature | Cardiac | Respiratory |
|---|---|---|
| Chest pain | Angina, pressure-like | Pleuritic (sharp, worse with breathing) |
| Cough | Pink/frothy sputum (pulmonary edema) | Purulent sputum, chronic productive cough |
| Ankle/leg swelling | Common (right heart failure/congestion) | Uncommon unless cor pulmonale |
| Wheeze | Cardiac ("cardiac asthma" in pulmonary edema) | Classic in asthma/COPD |
| Crackles | Bibasilar, fine (pulmonary edema) | Coarse, focal (pneumonia), fine (ILD) |
| Clubbing | Congenital cyanotic heart disease | Bronchiectasis, ILD, lung cancer |
| Palpitations/syncope | Common with arrhythmia | Uncommon |
| Fever | Uncommon (unless endocarditis) | Common (infection) |
| JVP | Raised in heart failure | Usually normal |
6. Onset
Acute dyspnea can arise from either system - myocardial ischemia, heart failure, tamponade (cardiac) versus pneumothorax, pulmonary embolism, acute bronchitis/pneumonia, or upper airway obstruction (respiratory) (Goldman-Cecil Medicine, p. 2516). Chronic dyspnea from CVS disease is usually from long-standing left ventricular failure or valve disease, while chronic respiratory dyspnea reflects ongoing airway or parenchymal disease (COPD, ILD).
Practical bedside approach
History (orthopnea/PND, edema, chest pain character, sputum, fever, smoking history), examination (JVP, crackles vs wheeze, edema, clubbing), and simple tests (ECG, chest X-ray, BNP/NT-proBNP, spirometry) usually separate the two. Note that overlap is common - e.g., heart failure can cause wheeze ("cardiac asthma"), and COPD can strain the right heart (cor pulmonale), so clinical correlation with investigations is required for a firm diagnosis.
Recent evidence check: A 2025 systematic review on dyspnea in mechanically ventilated patients (PMID: 40227090) and a 2023 review on invasive cardiopulmonary exercise testing for unexplained dyspnea (PMID: 36345986) don't contradict this classical framework but highlight that in genuinely unclear cases, exercise testing can help unmask a mixed or occult cardiac/pulmonary contribution not evident on standard workup.
State proper diff between cvs brethlessness and rs brethlessness
Finding Sources
Finding Sources
Reading File
Reading File
I now have solid textbook-backed material (Harrison's 22E and Goldman-Cecil, plus Fishman's Pulmonary Diseases) to build a clean, proper differentiation table.
Differentiating CVS Breathlessness vs RS Breathlessness
Per Harrison's Principles of Internal Medicine: "In a patient with dyspnea, the clinician must distinguish cardiac from pulmonary causes, although the differentiation may be difficult... differentiating dyspnea related to HF versus pulmonary disease may be impossible when the diseases coexist" - so these are the classical distinguishing clues used when disease is not mixed.
| Feature | CVS (Cardiac) Breathlessness | RS (Respiratory) Breathlessness |
|---|---|---|
| Underlying mechanism | Rise in pulmonary venous/capillary pressure from LV failure or valve disease -> pulmonary congestion; or reduced cardiac output/ischemia | Airway obstruction, reduced lung compliance, or impaired gas exchange (parenchymal/pleural/airway disease) |
| Character | "Air hunger" - urge/need to breathe | Increased work/effort of breathing; chest tightness with bronchoconstriction |
| Onset in disease course | Often sudden in acute MI, arrhythmia, pulmonary edema, tamponade | Often gradual (COPD, ILD) but can be acute (pneumothorax, PE, severe asthma) |
| Orthopnea | Classic and prominent - must sit upright to relieve | Can occur in severe chronic lung disease too, but less specific |
| Paroxysmal nocturnal dyspnea (PND) | True PND - patient wakes gasping, must sit/stand for gravitational fluid redistribution | Nocturnal breathlessness in chronic lung disease is usually due to accumulated tracheobronchial secretions, relieved by coughing/expectoration rather than sitting up |
| Wheeze ("cardiac asthma" vs bronchial asthma) | Wheeze from tracheobronchial edema/bronchospasm in pulmonary edema; more likely to have diaphoresis and cyanosis | Wheeze from reactive airway disease (asthma/COPD); typically no diaphoresis/cyanosis unless severe |
| Chest pain | Angina - central, pressure/squeezing, exertional | Pleuritic - sharp, worse on inspiration/coughing (pneumonia, pneumothorax, PE) |
| Cough/sputum | Dry cough or pink, frothy sputum (pulmonary edema) | Purulent sputum (infection), chronic productive cough (COPD/bronchiectasis) |
| Edema | Bilateral ankle/leg edema, raised JVP (right heart congestion) | Uncommon, unless cor pulmonale from chronic lung disease |
| Auscultation | Fine, bibasilar crackles (pulmonary edema); S3 gallop | Coarse/focal crackles (pneumonia), diffuse fine crackles (ILD), prolonged expiration and wheeze (COPD/asthma) |
| Fever | Uncommon (unless infective endocarditis) | Common (respiratory infection) |
| Response to treatment | Relieved by diuresis (though relief not always proportional to fluid removed) | Relieved by bronchodilators/antibiotics/steroids depending on cause |
| Exercise tolerance pattern | Fatigue plus dyspnea together, worsens with minimal exertion in advanced HF | Dyspnea often with prolonged recovery time after exertion; may improve with rest and bronchodilator |
| Special associated features | Palpitations, syncope, cyanotic congenital heart disease may show squatting relief (e.g., Tetralogy of Fallot) | Clubbing (bronchiectasis, ILD, lung cancer), barrel chest (COPD), accessory muscle use |
| Useful investigations | Raised BNP/NT-proBNP, echocardiogram showing systolic/diastolic dysfunction, ECG changes, cardiomegaly on CXR | Spirometry (obstructive/restrictive pattern), CXR showing consolidation/hyperinflation/effusion, normal or low BNP |
Key confirmatory point (Harrison's, p. 2513)
A very low BNP or NT-proBNP level argues strongly against a cardiac cause, and pulmonary function testing after effective diuresis can help isolate the dominant cause when both coexist (common in elderly smokers with combined COPD and heart failure).
Summary in one line
- Cardiac dyspnea = air hunger, worse lying flat, relieved sitting up, associated with edema/raised JVP/gallop, relieved by diuretics, high BNP.
- Respiratory dyspnea = effort/tightness in breathing, associated with cough/sputum/wheeze/fever, relieved by bronchodilators/antibiotics, abnormal spirometry, normal BNP.
Bnp ?
Finding Sources
Searching PubMed
"natriuretic peptide" AND "heart failure" AND diagnosis
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I have solid material now to give a complete, well-organized answer on BNP.
BNP (B-type Natriuretic Peptide)
What it is
BNP is a 32-amino acid peptide hormone secreted mainly by the cardiac ventricular myocytes in response to increased wall stress/stretch (volume or pressure overload). It's synthesized as a prohormone (proBNP) that is cleaved by the enzyme corin into:
- BNP (biologically active) - half-life ~20 minutes
- NT-proBNP (inactive fragment) - half-life ~90 minutes, so it circulates at higher, more stable concentrations
(Braunwald's Heart Disease; Dermatology 2-Vol Set; Barash's Clinical Anesthesia)
What it does
Natriuretic peptides cause:
- Vasodilation
- Natriuresis (sodium/water excretion) - reduces circulating volume
- Decreased endothelin levels
- Inhibition of the renin-angiotensin-aldosterone system (RAAS) and sympathetic nervous system
Essentially it's the body's counter-regulatory response to try to offload the heart when ventricular pressure/volume is high.
Why it matters clinically - differentiating cardiac vs respiratory dyspnea
This is the key link to your earlier question: BNP is elevated when dyspnea is cardiac in origin (heart failure) and is typically low/normal when dyspnea is purely respiratory, making it a useful "rule-out" test at the bedside.
Diagnostic accuracy for heart failure in dyspneic patients (Symptom to Diagnosis, p. 294):
| BNP Cutoff | Sensitivity | Specificity | LR+ | LR- |
|---|---|---|---|---|
| < 50 pg/mL | 97% | 44% | 1.7 | 0.06 |
| < 100 pg/mL | 93% | 66% | 2.7 | 0.11 |
| < 250 pg/mL | 89% | 81% | 4.6 | 0.14 |
- A BNP < 100 pg/mL makes acute decompensated heart failure unlikely (this was the key finding of the landmark "Breathing Not Properly" study - a BNP of 100 pg/mL was highly accurate for diagnosing acutely decompensated HF).
- For NT-proBNP, an equivalent cutoff of ~900 pg/mL gives comparable diagnostic performance (PRIDE study).
- ACCF/AHA guidance: elevated BNP supports a diagnosis of HF but should not be used alone to confirm or rule out HF - it must be combined with history, exam, and imaging (echo is the test of choice).
Important caveats when interpreting BNP
BNP/NT-proBNP can be elevated without heart failure in:
- Renal failure (slower clearance)
- Pulmonary embolism (with RV strain) - can average 700-1900 ng/L
- Pulmonary hypertension
- Valvular disease, ischemic heart disease, atrial arrhythmias, constrictive pericarditis
- Cardiac amyloidosis (often markedly elevated)
- Sepsis / hyperdynamic states
- Advancing age
- ARNI drugs (sacubitril/valsartan) can modestly raise BNP (but not NT-proBNP, since NT-proBNP isn't degraded by neprilysin - useful if patient is on ARNI)
BNP can be falsely low in:
- Obesity (lower-than-expected values despite similar/higher wall stress - thought to be reduced gene expression, not just clearance)
Bottom line for your RS vs CVS breathlessness question
- Low/normal BNP -> argues strongly against cardiac cause -> look harder at respiratory causes.
- High BNP -> supports cardiac cause, but confirm with echocardiogram since PE, renal failure, and pulmonary hypertension can also raise it.
Recent evidence note: A 2025 systematic review/meta-analysis (PMID: 40219913) found machine learning models can improve the diagnostic accuracy of natriuretic peptides for acute heart failure beyond fixed cutoffs, and a 2023 meta-analysis (PMID: 36785511) confirmed natriuretic peptide screening has good accuracy for detecting LV systolic dysfunction in community populations - both consistent with, and refining, the classical cutoffs above.
This is a shared conversation. Sign in to Orris to start your own chat.